Nothing Special   »   [go: up one dir, main page]

AU1589492A - Starch-based controlled release compositions - Google Patents

Starch-based controlled release compositions

Info

Publication number
AU1589492A
AU1589492A AU15894/92A AU1589492A AU1589492A AU 1589492 A AU1589492 A AU 1589492A AU 15894/92 A AU15894/92 A AU 15894/92A AU 1589492 A AU1589492 A AU 1589492A AU 1589492 A AU1589492 A AU 1589492A
Authority
AU
Australia
Prior art keywords
starch
controlled release
release compositions
based controlled
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15894/92A
Inventor
Tsun-Ming Chen
Subraman Rao Cherukuri
Mahdi Fawzi
David J. Lentz
Antonio Moroni
Kuchi S Murthy
Galen W Radebaugh
Michael G Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU1589492A publication Critical patent/AU1589492A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
AU15894/92A 1991-03-01 1992-03-02 Starch-based controlled release compositions Abandoned AU1589492A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66417391A 1991-03-01 1991-03-01
US664173 1996-06-14

Publications (1)

Publication Number Publication Date
AU1589492A true AU1589492A (en) 1992-10-06

Family

ID=24664881

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15894/92A Abandoned AU1589492A (en) 1991-03-01 1992-03-02 Starch-based controlled release compositions

Country Status (2)

Country Link
AU (1) AU1589492A (en)
WO (1) WO1992015285A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292519A (en) * 1992-04-10 1994-03-08 American Maize Technology, Inc. Process for producing a pharmaceutical tablet using a homozygous white starch
EP0711166A1 (en) * 1993-07-22 1996-05-15 Warner-Lambert Company Controlled release tacrine drug delivery systems and methods for preparing same
US5565407A (en) * 1993-12-27 1996-10-15 University Of Kansas Center For Research, Inc. Biologically active agent encapsulated in biodegradable starch/polymer matrices
US5698224A (en) * 1994-06-27 1997-12-16 Alza Corporation Tacrine therapy
NL9401534A (en) * 1994-09-21 1996-05-01 Gijsbertus Gerardus Petrus Van Use of starch for parenteral applications.
NL9401703A (en) * 1994-10-14 1996-05-01 Rijksuniversiteit Chewing gum.
FR2747306B1 (en) * 1996-04-15 1998-05-22 Oreal USE OF A HYDROCARBON POLYMER FOR FIXING AND / OR EXTENDED RELEASE OF PERFUME
EP0992251A1 (en) * 1998-10-07 2000-04-12 Isotis B.V. Device for tissue engineering a bone equivalent
US6274168B1 (en) 1999-02-23 2001-08-14 Mylan Pharmaceuticals Inc. Phenytoin sodium pharmaceutical compositions
DE19918325A1 (en) * 1999-04-22 2000-10-26 Euro Celtique Sa Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
AU2003288588A1 (en) * 2002-12-16 2004-07-09 Ranbaxy Laboratories Limited An extended release pharmaceutical composition of phenytoin sodium
US20060233873A1 (en) * 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
US20080107733A1 (en) 2004-05-28 2008-05-08 Katja Fastnacht Formulation Obtained From A Powder Mixture Comprising An Inorganic Pigment
US9029427B2 (en) * 2005-11-11 2015-05-12 Asahi Kasei Chemicals Corporation Controlled release solid preparation
DE102006055477A1 (en) * 2006-11-24 2008-05-29 Bayer Cropscience Ag Crop protection granules for application to the leaf surface
US8486439B2 (en) 2007-03-01 2013-07-16 Bioneedle Technologies Group B.V. Parenteral formulation
SI2968529T1 (en) 2013-03-14 2021-03-31 Aimmune Therapeutics, Inc. Manufacture of peanut formulations for oral desensitization
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
CN105012265A (en) * 2015-08-19 2015-11-04 上海华源安徽锦辉制药有限公司 Pharmaceutical composition containing phenytoin sodium compound as well as preparation method of composition
RU2629595C1 (en) * 2016-09-08 2017-08-30 федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный медицинский университет имени В.И. Разумовского" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Саратовский ГМУ им. В.И. Разумовского Минздрава России) Preparation for soft tissue regeneration with antibacterial effect
RU2629596C1 (en) * 2016-09-08 2017-08-30 федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный медицинский университет имени В.И. Разумовского" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Саратовский ГМУ им. В.И. Разумовского Минздрава России) Powder preparation with antibacterial and regenerative effects
US11229673B2 (en) 2019-05-10 2022-01-25 Société des Produits Nestlé S.A. Methods for improving the quality of life of a patient with a peanut allergy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG46154A3 (en) * 1983-02-18 1989-10-16 Warner-Lambert Company Llc Method for preparing of capsules
IE66735B1 (en) * 1988-11-03 1996-02-07 Biotec Biolog Naturverpack Thermoplastically workable starch and a method for the manufacture thereof

Also Published As

Publication number Publication date
WO1992015285A1 (en) 1992-09-17

Similar Documents

Publication Publication Date Title
AU659473B2 (en) Slow release compositions
AU2746992A (en) Controlled release pharmaceutical compositions
AU1589492A (en) Starch-based controlled release compositions
AU6605894A (en) Opiod formulations having extended controlled release
AU3057492A (en) Controlled release flutamide composition
AU1118092A (en) Sustained release compositions
AU5939394A (en) Sustained release compositions
AU2963192A (en) Fullerene-polymer compositions
AU6196394A (en) Controlled release formulation
AU9174391A (en) Fire-extinguishing compositions
AU3432689A (en) Controlled release composition
AU2857092A (en) Polyol compositions
AU1806895A (en) Controlled release composition
AU1700892A (en) Release liner
AU1037792A (en) Plaster composition
AU2980592A (en) Insecticidal compositions
AU3792695A (en) Photoprotection compositions
AU1704292A (en) Polyisocyanate composition
AU7813491A (en) Modified dispersant compositions
AU1013992A (en) Lice-repellant compositions
GB2252043B (en) Controlled release compositions
AU2960892A (en) Immunogen composition
AU2395692A (en) Herbicidal composition
AU1164892A (en) Compositions
AU2962792A (en) Cementitious compositions